Latest AI and machine learning research in chemotherapy for healthcare professionals.
Reliable, minimally invasive biomarkers for predicting immunotherapy response in head and neck squam...
Background: Manual chart abstraction is a major bottleneck in clinical research. In oncology, import...
Regional lymph node (LN) metastasis critically influences distant metastatic progression, anti-tumou...
Major pathological response (pR) following neoadjuvant therapy is a clinically meaningful endpoint i...
Accurate prediction of biochemical recurrence (BCR) after radical prostatectomy is critical for guid...
Consensus molecular subtyping (CMS) defines the transcriptomic taxonomy of colorectal cancer (CRC) a...
Objective To develop and evaluate a scalable and reproducible natural language processing (NLP) appr...
Resistance to systemic therapy is a major unmet challenge in pancreatic cancer. To identify potentia...
The development and validation of prognostic and predictive biomarkers in breast cancer is limited b...
Lower-grade gliomas (World Health Organization [WHO] grades 2-3) exhibit variable treatment response...
Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause ...
Immunotherapy with immune checkpoint inhibitors and immunotherapy combined with chemotherapy have re...
Accurately predicting chemotherapy response remains a major challenge in precision oncology. Althoug...
Background: Traditional pharmacovigilance methods based on biostatistical approaches systematically ...
POLE sequencing for somatic mutations (POLEmut) guides adjuvant therapy in endometrial cancer (EC), ...
Background: Gastrointestinal stromal tumor (GIST) is the most common gastrointestinal mesenchymal tu...
The standard treatment for stage I lung adenocarcinoma is surgical resection, in most cases without ...
Chemotherapy has been widely used in cancer treatment, but most of the chemotherapeutic drugs rely m...
Background Stage III colorectal cancer poses a significant threat of metastasis development, as tumo...
Patient selection and enrolment into phase III randomized clinical trials (RCTs) of adjuvant cyclin-...
Selection of systemic therapy for breast cancer remains largely empirical, particularly for chemothe...